In contrast, previous studies have reported a protective effect of AhR agonist on CSCs of TNBC [44] and MCF-7 breast cancer cells via downregulation of Wnt/β-Catenin and Notch signaling pathway [45]. The gene discussed is AHR; the disease is breast carcinoma.